Introduction
One of the fundamental processes associated with post-transcriptional modification is protein folding. During this phase of protein modification,n umerousp roteins undergo misfolding or partial unfolding. [1] These unfolded or misfolded proteins then becomer esponsible for diverset ypes of diseases and disorders, such as Alzheimer's disease, Huntington disease, Parkinson's disease, and transmission spongiform encephalopathy. [2] [3] [4] [5] [6] Mainly,t hesem isfolded proteins are richi nb-sheet structures and are insoluble in most solvents of ap hysicochemical nature. [7, 8] These proteins tendt oaggregate into amyloids or amorphous-like structures, which furtheri nvolves cellular damage and organ dysfunction. [9] The principle behind the development of amyloid fibrils is linked to severals teps, such as dissociation or association of protein native structures that further form seeds for nucleation,e longation of the fibrillar aggregates, and finally the formation of larger fibrils or large aggregates such as floccules and tangles. [10] [11] [12] [13] Nevertheless, the present understandings of the inhibition of amyloid fibrils remain unsolved.
Insulin can cause type II diabetes if defects occur in insulin metabolism. [14] There is also ag reat role played by insulin in the formation of "amyloidoma"a tt he site of injection of the patientt akingi nsulin intravenously.I nt hose cases, insulin starts to deposit in large amounts and forms an amyloidoma, which is pathogenic.
[15] Likewise, this aggregation of insulin has hadagreat effect on drug discovery. [16] Insulin, a5 1-residue protein, undergoes partial unfolding or misfolding in vitro. [17] Insulin is ah exameric protein under physiological conditions, and it binds with two or four Zn + ions. [17] Monomeric insulin consistso fo ne Achain of 21 residues and one Bchain of 30 residues. [18] The aggregation of insulin mainly comprises noncovalent interactions. During aggregation,t he disulfide bonds present in the insulin monomer remainu nchanged, so they provide asubstantial topological limitation, which thus results in twistingo ft he Achain. [19, 20] Upon heating and under acidic conditions, insulins tarts to misfold and forms amyloid assemblies. [21] Bovine insulin differs from human insulinbyo nly three aminoa cids (A8 Ala-Bov/Thr-Hum,A 10 Val-Bov/ Ile-Hum, and B30 Ala-Bov/Thr-Hu), and it also aggregates more easily in vitro, so it shows better resultsa samodel to study protein aggregation. [22] Several experimental studies on insulin indicate that the Na nd Ct ermini of the Bchain play crucial roles during the fibrillation process. [23] The characteristics of the fibrils formed by insulin are analogous to those of other amyloids with similar X-ray diffractionc onfigurations and rich in bsheet structures, and these fibrils show affinity towards thioflavin Tand Congo red dyes, which are highly stable at high temProtein misfolding is interrelated to several diseases,i ncluding neurodegeneratived iseases and type II diabetes. Misfolded/unfolded proteins produce soluble oligomers that accumulate into "amyloid plaques". Inhibition of amyloid-plaquef ormation by those misfolded/unfolded proteins will lead to the invention of new therapeutic approaches for amyloid-related diseases. Herein, methylene blue (MB), aw ell-defined drug against multiple diseases and disorders, is used to impede insulin fibrillation. In this study,w ep erform an array of in vitro experiments to monitor the effects of MB on the fibrillation of bovine insulin.Our resultsconfirmthat MB distresses the kinetics of insulin fibrillation by interacting with insulin in its monomeric form. At hioflavin Tassay indicates that insulin fibrillation is interrupted upon the addition of MB. The same resultsa re confirmed by circulard ichroism, dynamic light scattering (DLS), and size-exclusion chromatography (SEC). According to the DLS data, the insulin fibrils are 800 nm in diameter,and the addition of MB reduces the size of the fibrils, which remain 23 nm in size, andt his indicates that no fibrillation of insulin occurs in the presence of MB. Thisd atai sa lso supported by SEC. Saturation transfer differenceN MR spectroscopy andm olecular dynamics simulations demonstrate the interactions between insulin and MB at the atomicl evel.
peratures and to proteases. [24] [25] [26] [27] In ar ecent study,i tw as also shown that fibrils couldb ed etected by probing the protein with biphenyl-group-grafted polyamido amine( PAMAM). [28] The exact reasons behind this insulin fibrillation and its inhibition are still to be settled. [29, 30] From this point of view,t he reason behindd eliberately improving the experimental and theoretical conclusions to resolve this cause and to produce the appropriate drug is linked to the numerous steps of insulin aggregation.
Af ew experimental studies have outlined the inhibition of tau phosphorylation [31] and scrapie formation of prion by phenothiazine compounds. [32] Methylene blue (MB) is ap henothiazine derivative and ac ationic dye with the chemicaln ame tetramethylthionine chloride, and it was already shown to have druglikebehavior in treating malaria, [33] frontotemporal dementias, [34] and severalb acterial and viral infections. [35] Precisely,i t is the first synthetic compound used as ad rug therapeutically.
[36] Also, MB and its derivatives were used in chemotherapy before the discoveryo fr elatedd rugs. [37] In recent times, the potencyofMBtosuppress cognitive declineinAlzheimer's disease (AD) patients was shown. [38, 39] Necula et al. performed biochemicals tudies and showedt hat MB inhibited Ab42 oligomerization with am oderate inhibitory concentration( IC 50 )v alue of 12.4 mm in vitro, [40] whereas Ta niguchie tal. reported an IC 50 value of 2.3 mm for the same reaction. [41] In ad ose-dependent manner, MB shows its inhibition effects on Ab42 aggregation. In-depth analysis also revealed thatt he oligomerization process of the Ab42 oligomers was converted into af ibrillation processa fter the addition of MB. [40] To the besto fo ur knowledge, the functiono fM Bi ni nhibiting the insulinf ibrillation process has not been reported.
In this study,w es how that MB interacts with insulin monomers and inhibits its fibrillation process. At different concentrations of MB with the insulin monomers, we observed that the highest concentration of MB used was the superlative concentration to inhibit the fibrillation process. All experiments were performed at two different pH values (pH 2.6 and 7.2). The reason behind the two differentp Hv alues was to confirm whether MB acted the same at different pH values. Our physiological conditions were neutral, in that determining how MB workedw as one of our aims. We confirmed the inhibition action by performing several in vitro experiments. Our first experiment was at hioflavin Ta ssay,b yw hich we found that upon heating and incubating insulin-MB at pH 2.6 for2 4h and insulin-MB at pH 7.2 for 42 h, no fibrils were formed in the insulin-MB complexes. The same conditions were maintained forp erforming circular dichroism (CD) experiments, and here also, we learnedt hat insulin withoutM Bf ormed fibrils and showed a b-sheet structure, whereas the a-helicals tructure of insulin remained the same in the presence of MB. Scanning electron microscopy (SEM), isothermal titrationc alorimetry,a nd size-exclusion chromatography (SEC) were performed to determine the mechanism behind the interaction of MB with the insulin monomers. We treated cells with insulin-MB fibrillateds amples to determine the inhibition effect of MB on insulin fibrillation. Further,s aturation transfer difference (STD) NMR spectroscopy( NMRa nd T 1 , T 2 relaxation) in conjunction with molecular dynamics simulations were employed to observe the atom-specific interaction of MB with insulin.
Results and Discussion

Fibrillation Study by the Thioflavin TAssay
Thioflavin T( ThT) dye is highly sensitive to the construction of fibrils.T hT dye interacts with amyloid fibrils without changing the structure or sequence of the proteins. [42] The dye hase mission and excitation bands at l = 480 nm and4 40 nm, respectively.T he mechanism by which ThT dye indicates amyloid fibrils is that the ThTd ye binds with the fibrils as fibrillation occurs, and its emission intensity steadily increases. In this study,w ep erformed time-dependent analysis of insulin fibrillation to identify the lag time, and we also measuredt he utilization of the small molecule. We observed that if the insulin (50 mm)m onomers were independently heated, they started to show an increase in the emission spectrum after 11 hi nc itrate phosphate buffer pH 2.6 and after 20 hi ns odium phosphate buffer pH 7.2 (Figures 1a and 2a) . After 17 and 37 ho fh eating incubation, the fibrillation process gradually started to saturate for insulin at pH values of 2.6 and 7.2, respectively.W eo btained as igmoidal curve, from which we concluded the phases of the fibrillation process. This sigmoidal curve represented a three-phase process:l og, lag, and static phases,s imilart ot he bacterialg rowth curve pattern. We obtainedt he lag or nucleation phase, the elongation or log phase,a nd the saturating phase. From this curve, we concluded that the nucleationp rocess of insulin fibrillationw as sustained up to 11 h, after which it entered the elongation process and continuedf or another 6h;t hen, it finally entered the saturation phase at 17 h( at pH 2.6). From 11 to 17 ht here was am aximum increase in the emission spectrum of ThT,w hich could be the exponential phase, and the duration of this saturation was the static phase for the entire fibrillation process (showni nF igure 1a). Correspondingly,a tp H7.2, we found that for insulin in the absence of MB the lag phase was up to 20 h; this wasf ollowed by graduale ntering of the exponential phase, which continued for 37 h. After that was the saturation phase. We added the MB during insulinf ibrillation process in am ean of concentration approach. MB wasu sed at different concentrations (1:50, 1:100, and 1:500 ratios). At an insulin/MB concentration ratio of 1:50, insulin fibrillation showed al ag phase at 16 ha tp H2.6, and the emission was less intense than the emission for free insulin fibrillation.A tt his 1:50 ratio, we postulate thatM Bmay interactw ith af ew insulin monomers due to the low concentration of MB, so the emission intensity cannot reach the emission intensity of the free insulin fibrils. At an insulin/MBc oncentration of 1:100, the effect was more apparent than the effect observed as a1 :50r atio. An insulin/MB concentration of 1:500 workedt he best. No fibrillation was observed even after 24 ho fi ncubation at pH 2.6. This comparative study is shown in Figure1a. The complexes with 1:50 and 1:100 ratios of insulin/MB enter the exponential phase after 28 and 32 ha tp H7.2, respectively ( Figure 2a ). However,a sp reviouslys aid for pH 2.6, the intensitieso ft hese two 1:50 and 1:100 MB-insulin com- plexes are much lower than that of insulin alone. The complex with insulin/MB = 1:500 showedn oi ncreasei nt he intensity, even after incubating for 42 h ( Figure 2a ). The fluorescence of MB was also measured at l = 450 to 480 nm, and no increase in the fluorescencei ntensity was observed. Thus, we can say that the increase in the intensity of insulin in the presence of MB is ar esult of the inhibition effects of MB towards fibrillation. MB was always added to the initial state before incubation was started.
Circular Dichroism Spectroscopy as aM eans To Reveal Structural Characteristics
Insulin is ag lobular protein that includes three a helices. During the fibrillation process, several kinds of conformational changes occur in the insulin structure. Insulin forms either an amyloid-like structure or amorphous aggregates at the stage preceding fibrillation. These amyloid fibrils are rich in b-sheet conformations. Hence, if an ormal protein undergoes the fibrillation process, ap hase transition of the a helix towards a bsheet conformation emerges.I no ur study,afreshly prepared insulin sample was incubated in the presence and absence of MB at 50 8Cf or 24 hf or insulin-MB pH 2.6 and for 42 hf or insulin-MB pH 7.2, and all the spectra were taken at different time intervals. We also used ad ifferent concentration of MB to determine the optimum concentration at which it blockedi nsulin fibrillation. We observed that free insulin in its initial state (beforeheating) adopted an a-helicalc onformation, which was apparent from the presence of two negative ellipsesa tl = 208 and 222 nm. As the free insulin increased in size due to fibrillation at 50 8C, its negative ellipticity gradually decreased with time. The ellipticity decreased from À48 to À4mdeg (Figure 1b,c) a tp H2.6 and from À29 to À8mdeg at pH 7.2. Interestingly, insulin, in the presence of MB (1:500) at pH 2.6 and pH 7.2 at 50 8Cr etained its conformation even after 24 and 42 ho fh eating incubation, respectively (Figures 1b,c and 2b,c).
At insulin/MB ratios of 1:50 and 1:100, we noticed that after 24 ho fi ncubation, the ellipticityd ecreased by 20 mdeg, but at pH 7.2, there was no such change in the ellipticity.I nc onclusion, we can say that at theset wo concentrationr atios of insulin/MB, secondary structures other than the a helicesw ere To analyze the percentages of helices, b sheets, and randomc oils, we deconvoluted the raw data by using CDNN software(Ta ble S3 a-d in the Supporting Information). From this analysis, we learned that the helicity of free insulin at pH 2.6 decreased from 61 to 12 %, whereas increases in b sheets (18 to 37 %) and randomc oils (17 to 57 %) were observed. In the MB-insulin complex, no substantial change in the overall secondary structure of insulin was observed relative to that of free insulin, even after 24 ho f incubation. The percentages of helices, b sheets, and random coils were slightly different from the percentages of the t = 0min conformations. The changes were from 52 to 45 %for insulin/MB = 1:50, 52 to 45 %f or insulin/MB = 1:100, and 48 to 48 %f or insulin/MB = 1:500 for the a helices. Similar changes in the b sheets and randomc oils were also observed (Table  S3a , b). The CDNN results for pH 7.2 are listed in Ta ble S3c, d. These resultsi ndicatet hat MB binds with the insulin monomers and changes its conformation,a st he epitopes for aggregation may remaini nb uried conformations. By interacting with the insulin monomers, MB inhibits insulin oligomerization. After comparing our CD experimentalr esults with the results obtained by Wang et al., [42] Kachooei et al., [43] and Banerjee et al., [44] we found that MB retained the secondary structure of insulin with more efficiency.
Increasing the Size of the Oligomer as Studied by Dynamic Light Scattering
After circular dichroism analysis, by which we delineated the changes in the secondary structureo fi nsulin, we wanted to investigate the effect of changing the size of insulin by dynamic light scattering (DLS). In DLS, light is scattered due to the presence of protein aggregates or any noise. The DLS experiment showedt hat the hydrodynamic radius of insulin in the presence and absence of MB after incubating for 11 hw as 0.5 and 50 nm, respectively.I ncreasingt he incubation time of insulin resultedi nalarger radius. In the initial state, however, there was no fibrillation, and thus, in the presence of MB the hydrodynamic radius of insulin remained almost the same. As the time increased and fibrillation started, the hydrodynamic radius also increased. At 12 h, the insulin samples were measured, and they gave ad iameter of 1 mm,b ut after 12 ht he size increased so much that furtherm easurements were not possible and errors appeared. On the other side, the radius of insulin in the presence of MB (at ratios of 1:50 and 1:100) was measuredu pt o2 0h.A fter 20 h, the size increased, so no further measurement was possible. For insulin with MB (1:500), no such increasei ns ize was observed, even after 24 ho fi ncubation (Figure 1d ). Only 0.1 %o ft he total population showed al arge size, but 99 %o ft he total population showed no increase in size. During the total time of the measurement, the diameter of the insulin sample remained within 20 to 40 nm. On the other hand, at pH 7.2, the resultsw ere almost similar to those obtained at pH 2.6, and insulin/MB = 1:500 worked the best. Here, the insulin lag phase started at 24 ha nd exponentialp hase lasted for 32 h, so the measurement was done up to 32 hfor insulininthe absence of MB (Figure 2d ). However,a fter 42 ht here was no such increasei nt he dynamic radius of insulin in the presence of MB (1:500).
Size-Exclusion Chromatography Strongly Supports DLS Results
Size-exclusion chromatography was performed to confirm whether the insulin monomers were binding with the small molecule or not. As insulin stays in the monomeric state, the elution peak came at 42 mL of the total volumeoft he column. However,u pon loading the insulin fibril in the column, the elution peak came at 12 mL. The insulinm olecule treated with the small molecule also shown ap eak at 42 mL of the eluted buffer,w hich was very similar to the insulinm onomer (shown in Ta ble S1). The principle behind electrophoresis is that larger sized molecules will move faster than smaller sized molecules. Due to higher mass, the large molecular aggregatesr un fast, and small molecular aggregates run much more slowly.I fi nsulin was not heated, it remained in the monomer state, which was only 5.8 kD in mass, so it eluted last at 42 mL. If the insulin molecule was heated, it formed fibrils, which are large. These large-sized insulin fibrils then acquired higher mobility and ran fast, so they eluted in the very first session of columnc hromatography.T he spectra of the 42 mL eluted sample of the insulin monomer and insulin treated with the small molecule were similar;t hey both showed peaks at 276 and 238 nm, which are specific to insulin monomers. On the contrary,t he insulin fibrils did not retain ab and at 276 or 238 nm. The spectrum of the insulin fibrils was flat. The figure is shown in Figure 3 . Previous studies on the inhibition of insulin fibrillation revealed that monomeric insulin eluted at last, but as the fibril structure grew,i te luted at the beginning. [45] [46] [47] As we already showedb y using dynamic light scattering and the thioflavin Ta ssay that the fibrillation process is repressed in the presence of the small molecule, by size-exclusion chromatography we can now validate that if the insulin monomersa re treated witht he small molecule its fibrillation process is blocked.
Thermodynamics of Binding as Exemplified by Isothermal TitrationCalorimetry
Another important experiment to detect the bindinge nergy of the receptor-ligand interaction is isothermal titrationc alorimetry (ITC). The change in enthalpy resulting from binding of two different charged molecules was measured by ITC. To see the thermodynamics of binding between the insulin-MB complex, we performed an ITC experiment at 25 8C, and 80 mm insulin was titrated with 2.5 mm MB in citrate phosphate buffer at pH 2.6 and with sodium phosphate buffer at pH 7.2. The titration curves were fitted to ao ne-site bindingm odel at pH 2.6 and to at hree-site bindingm odel at pH 7.2, as shown in Figure Figure 4a ,b.A ll the thermodynamic parameters, free energy change (DG), enthalpyc hange (DH), and entropy change (DS), were found to be negative, which demonstrates that the entropyo ft he solvent molecules released from the site of binding is highly positive, whereas the atomicm otion of the receptor as well as that of the ligand is reduced to al arge extent because of the formation of ah ydrogen bond between insulin and MB;t his dictates ad ecrease in the enthalpy of the whole complex. The resultant effect of enthalpy and entropyr esults in an egative DG value for complexation.
Morphological Study of the Fibrils by ScanningElectron Microscopy and Confocal Microscopy
To confirmt he contribution of MB to inhibition of insulin fibrillation, we used scanning electron microscopy (SEM)and confocal microscopy.A ll samples of insulin and MB at pH 2.6 and pH 7.2 were incubated for2 4a nd 42 ha t5 08C( insulin/MB = 1:500), and none of the samples showed fibril-like morphology. However,a ti nsulin/MB ratios of 1:50 and 1:100, some amorphous aggregates werefound. To validatet his insulin morphology,w ea lso performed confocal electron microscopy.I nsulin incubated withoutM Bs howed af ibril structure, as observed by SEM, but if it was incubated with MB (insulin/MB = 1:500), no such fibrillars tructure was found (Figure 5a,b) . From this incubated sample, an aliquot of 10 mLw as kept aside to prepare as ample for confocal microscopy.T he confocal microscopy results demonstrated thatt he insulin sample without MB had af ibril nature,a nd in the presence of MB there was no fibrillar morphology( Figure 6 ).
Atomic-Level Studybyu sing STD-NMRSpectroscopy and T 1 /T 2 Relaxation NMR Spectroscopy
STD NMR spectroscopy is an indispensable technique to unravel the keyr esidues of al igand that interactw ith the receptor at atomicr esolution. Ao ne-dimensional STD NMR spectroscopy experiment wasp erformed to identify the important protons of MB that interactw ith insulin. In the STD NMR spectroscopy experiment,a ne xcess amount of the ligand ( % 100-fold molar excess) relative to its receptor was used with ad issociation constant in the low micromolar to millimolar range. The STD signalw as produced by effective magnetization transfer from the receptor to the ligand in its bound state. STD NMR spectroscopy provided us with the bindings ite or epitope for MB, which is shown in Figure 8a .F rom the STD-NMR spectroscopy experiment, we can say that the 1-CH, 2-CH, 3-CH, and 4-CH protons of the aromatic ring interact with the insulin monomers and that the 1-CH 3 group also interactsw ith insulin. The PyMOL structureo fM Bw ith the protons marked is shown in Figure 8b .T or eveal the atomic-level dynamics of MB and the MB-insulin complex, one-dimensional longitudinal (R 1 = 1/T 1 ) and transverser elaxation (R 2 = 1/T 2 )e xperiments were performed. The longitudinalr elaxation rate (R 1 )o ft he MB-insulin complex was significantly lower than that of free MB for all amide protons (Figure 8c,d) . The rate of longitudinal relaxation is proportionalt ot he correlation time (t c ). The conformational dynamics of free MB are restricted in the presence of insulin. The decrease in the correlation time is reflected in ar eduction in the rate of longitudinal relaxation. Similarly,t he transverse relaxation rate (R 2 )f or all the residueso fM Bw as increased in the presence of insulin.
InsulinPathway Study By TreatingHepG2 Cells with Insulin in the Presence and Absence of MB
Cells were treated with fibrillated insulin prepared with or withoutt he different molar ratios of MB, and phosphorylation of Akt at Ser473 in the whole-celll ysates was analyzed as a readout for insulin signaling.O ur resultss how that phosphorylation of Akt was enhanced upon increasing the concentration of MB with am aximal effect at insulin/MB = 1:500. These data suggest that dose-dependent inhibition of insulin fibrillation by MB also improved cellular insulin sensitivity (Figure 7 ). 
Molecular Dynamics Simulation ProvidesAtomic Level and StructuralA nalysis
Am olecular dynamics (MD) simulation showedi nsighti nto the mechanism of binding in the MB-insulin interaction. In our dynamics part, residues 1t o2 1a re from chain Aa nd residues 22 to 51 are from chain Bo ft he insulin monomer.D uring this total simulation run, we observed that MB interacted with insulin mainly through the hydrogen atoms of the phenol rings. The interactions were mostly hydrogen bonds and van der Waals interactions;a ll are shown in Figure S1 a. These interactions between MB and insulin were also found by STD-NMR spectroscopy.T he MD simulationg ave detailed information about complex formation at the atomic level. [48, 44] In its mean individual solvent, molecule MB adjusts its position with regard to the initial docked state. [49] The binding ratio obtained from ITC was found to be 1:1f or the insulin-MBc omplexa t pH 2.6. Hence, we docked MB and insulin up to a1 :1 ratio. To gain more information at the atomicl evel, the MD simulation was performed for 100 ns for the insulin control and for the 1:1i nsulin-MBc omplex. The average structures of the insulin control obtained from the MD simulationw ere superimposed in the final 100 ns of the trajectory at intervals of 10 ns (Figure S2) . Similarly,t he average structures of the insulin-MB complex were superimposed in the final 100 ns of the MD simulation( Figure S3 ). We determined conformational maintenance and distinctions on the basis of the root-mean-square deviation (RMSD) values. Ah igh RMSD value indicates af lexible nature of the protein, whichc auses overall instability of the protein's secondary structure. [50] Cpptraj script were incorporated to calculate the RMSD values. [51] Thee quation used to calculate the RMSD values is [Eq. (1)]:
in which N is the total number of atoms under consideration and d is the distance betweent he two positions of N pairo f equivalent atoms. Figure 8e shows the RMSD plot of the insulin controla nd the 1:1i nsulin-MB complex over the simulation timescale. The stabilityo ft he trajectories of the complex can be observed with minimal fluctuation ranging from 2t o2 .8 . The RMSD plot of the complex was stable over the entire simulation timescale, from whichi tc ould be concluded that MB stabilized insulin. Figure 8fshows the root-mean-square fluctuation (RMSF) of the insulin control and the insulin-MB complex. In this report, we observed the folding of insulin in the free state and bound with MB and the pattern of MB binding. The RMSD was calculated for at otal time of 100 ns (Figure 8e ). During the entire simulation, the MB-insulin complex overcame the lower RMSD trend, whereas free insulin had ah igher RMSD value. Also, after 4000 frames the overall RMSD was retained at around 2.0 for the insulin complex, but after 4000 framest he RMSD of free insulin was around2to 4.0 .T he RMSD results indicatet hat free insulin is highly flexible, that is, there is ac ontinuous changei ni ts conformation. This highly flexible state will possibly lead to instability of the insulin monomer,w hich might be the reason why it forms aggregates. However,t he MB-insulin complex with al ower RMSD suggests that MB stabilizes the secondary structure of insulin.T he structural stability of insulin resulting from MB might be the reason for the inhibition of insulina ggregation.T herefore, we can approximately propose that inhibition of the fibrillation process of insulin happens if MB interacts with the insulin monomers. Hua et al. [18] illustrated the structural characteristics of insulin on the basis of biophysical analysis, and they found that the N termini of chain Aa nd chain Bo ft he insulinm onomer were not in an orderedf orm during the fibrillation process. Also, the Ct erminus of chain Bf ormsaBturn under normal conditions; however,d uring fibrillation this segmentf orms ah elix-like structure. [18] The N-terminal residues of chain Aa nd chain B, which are mainly involved in the aggregation process,a re I2, V3, andC 6f or chain Aa nd F1, V2, and C6 for chain B. Thep artial disordered nature of chain Aa nd chain Be xposes possible sites of aggregation.T he molecular dynamics results also indicate as imilar situation in that if MB is in ab ound state with insulin, the N-terminalf ragment of chain Am aintains as tructure that is similar to the initial structureo fi nsulin > .H owever,f ree insulin gives differentr esults and shows that the N-terminal fragments of the Achain are exposed compared to the initial insulin structure (shown in Figure S1 b). The RMSF analysisi si llustrated in Figure 8f ,a nd it can be concluded that chain A (residues1-21) and chain B( residues 22-51) are less flexible in the insulin-MB complex than in free insulin.H owever, certain residues of free insulin in chain B( residues 28,3 7, 38, 39, and 40) and chain A( residues1 to 8) show high fluctuationd uring the simulation runtime.U pon binding of insulin with the peptide, there were no such changes in theser esidues.R esidues 1-8 of chain Ah ave ah elix structure, so less fluctuation in theser esidues in the presence of MB suggestst hat MB stabilizes the helix of insulin, which is an indication that the fibrillike structure is not formed during the total simulation run. The molecular simulation study offers mechanistic insight into how MB interacts with the insulin monomer.
Conclusions
We showedi nt his report that methylene blue (MB) interacts with insulin monomers in ar atio of 500:1 and displays inhibition effects on the aggregationp rocess of insulin. We used different concentrations of MB to check the inhibition effect, and we found that if the insulin/MB ratio was 1:50 or 1:100 no such fibrillars tructure was formedb ut amorphous aggregates were present. As we increased the concentrationo fM B, we found that the fibrillation process, as well as the formation of amorphousa ggregates,w as blocked. Previous experiments performed by Wang et al. [52] and Choudhary et al. [53] were performed with highc oncentrations of the inhibitors to inhibit insulin fibrillation. Our molecule also workedb esta th igh concentrations. Our hypothesis was supported by variouse xperiments,t hat is, thioflavin T( ThT) assay,c ircular dichroism (CD), dynamic light scattering (DLS), size-exclusion chromatography (SEC), scanning electron microscopy (SEM), confocal microscopy,a nd Akt phosphorylation assay performance. Interaction of MB with the insulin monomers was confirmed by saturation transfer difference (STD) NMR spectroscopy,isothermal titration calorimetry (ITC), and molecular dynamics experiments.F rom the STD NMR spectroscopy and molecular dynamics experiments,w ef ound that the hydrogen atoms of MB interactw ith the insulin monomers. The hydrogen atoms of the aromatic ring interactw ith the insulinm onomers. Also, the molecular dynamics and docking results suggested that MB interacts with ah elix of the Bchain of the insulin monomer.D uring a total simulation run of the MB-insulin complex, it remained bound with insulini nt hat particularp osition. Upon treating the HepG2 cell line with fibrillated insulin in the presence and absence of MB, we observed that the complexw ith a1 :500 ratio of insulin/MBs howedA kt phosphorylation, as MB inhibited fibrillation of insulin, so the concentration of monomeric insulin remained high. By performing the abovementioned experiments, we concluded that the insulin-MB complex was far more stable than free insulin and the dissociation of MB from insulin was also not possible even at high temperatures/acidic pH values as well as at low temperatures. However,i tw as previously reported that MB inhibited tau phosphorylation [31, 41] and also abeta-42, [40] and we further assume that this type of drug can act in both diseases at as ingle time. MB has shown diversep otentiali ni mpeding protein aggregation and proves to be al ead for developing better therapeutics.
Experimental Section Thioflavin TAssay
Thioflavin Tisad ye specific for the detection of protein fibrillation. It has an excitation wavelength at 440 nm and an emission wave- length at 480 nm. We prepared insulin in citrate phosphate buffer pH 2.6 and sodium phosphate buffer pH 7.2. In both cases, the concentration of insulin was 50 mm.T he small molecule was co-incubated with the insulin monomers at the very beginning of the experiments. At several time intervals, data were collected. The small molecule was used at different concentrations, that is, insulin/MB = 1:50, 1:100, and 1:500.
Circular Dichroism (CD)
Secondary structural changes in insulin over time were analyzed by circular dichroism. Insulin is ag lobular protein that shows ah elical structure at l = 222 and 208 nm. All spectra were analyzed by aJ asco 815 circular dichroism spectropolarimeter at 25 8C. The final concentration of insulin was 25 mm.T he scanning wavelength was from 200 to 260 nm. The speed of each scan was 100 nm s À1 ,a nd the bandwidth was 1nm. The results of each spectrum are averaged over three scans. Buffer's spectra were subtracted from the insulin spectra. All the spectra were measured in at ime-dependent manner.
ScanningElectron Microscopy (SEM)
Scanning electron microscopy is al ow-resolution instrument that takes images of am olecule'sm orphology.I nsulin samples (50 mm) were incubated with and without MB at 50 8C. From the incubated insulin samples, aliquots (5 mL) were taken for SEM analysis. Samples were coated with gold in an Edward'sS 150 Sputter Coater before scanning. Finally,i mages were taken by using an FEI QUANTA200 scanning electron microscope. Insulin was mixed with MB in ratios of 1:500, 1:100, and 1:50.
Confocal Microscopy
Confocal microscopy is also another microscopy technique that can be used to confirm SEM data. It uses the fluorescence of the molecules to conduct the imaging. For all analyses, a2 0 or 40 oil immersion objective was used with af luorescence microscope (DMRE, Leica, Germany) equipped with one beam splitter (488) and FW TD 488/543/633 beam-splitting excitation mirrors. All samples were prepared as previously described for the SEM experiments. Those samples were spread on ag lass slide and covered with acover slip. The edges were then glued.
DynamicLight Scattering (DLS)
DLS studies were performed with Malvern nanodynamic light scattering equipment. The insulin sample was taken at ac oncentration of 50 mm in the presence and absence of MB for analysis. All the samples were filtered through am icrofilter with ap ore size of 0.2 mm.
The measured size is presented as the average value of 25 runs. Dynamics 7.10.0.10 software at optimized resolution was used for data analysis. The mean of the hydrodynamic radius (R h )a nd polydispersity (P d )w as assessed by using the Stokes-Einstein equation [Eq. (2)]:
in which R h is the hydrodynamic radius, k is the Boltzmann constant, T is the absolute temperature, g is the viscosity of water,a nd D25uCw is the translational diffusion coefficient.
Isothermal Titration Calorimetry (ITC)
The ITC experiment was performed at 25 8Cw ith VP ITC Micro Calorimetry equipment. The insulin solution was taken in ac ell, MB was taken in as yringe, and the buffer was taken in ar eference cell. We experimented with buffers of pH 2.6 and pH 7.2. The insulin solution was stirred at 300 rpm by the syringe. This titration of insulin with MB was performed for at otal of 14 injections. The first injection was of 1 mL, which was not assumed in the analysis, and all the remaining injections were 3 mL. The heat of dilution was subtracted from the main titration data. After equilibration was reached, only then was the titration started. All the data were analyzed in origin software. The heat change (DG)a nd the entropy change (DS)w ere calculated from the thermodynamics law equation.
Size-Exclusion Chromatography (SEC)
Size-exclusion chromatography was performed at room temperature with aB iorad torosh column. The insulin was taken in 1mgmL À1 .M Bw as added in a1:500 ratio. After 24 ho fi ncubation at 50 8C, the samples were separately run in the column. The total column volume was 50 mL. The void volume of the column was 15 mL. We started to collect the sample after the void volume was released. At otal of 50 mL of the sample was collected from the column for each sample.
NMR Spectroscopy (STD NMR, T 1 and T 2 Relaxation)
To perform the STD NMR spectroscopy experiments, we prepared samples in 99.0 %D 2 O, and the pH was adjusted to 2.6. NMR is a high-resolution spectroscopy technique used to detect structure, dynamics, and interactions between molecules. All NMR spectra were recorded by using aB ruker AVANCE III 500 MHz spectrometer equipped with a5mm SMART probe at 298 K. Data acquisition and processing were performed by using To pspin 3.1 software. All NMR samples were prepared in 50 mm citrate phosphate buffer containing 10 %D 2 Oa nd using trimethylsilylpropanoic acid (TSP) as an internal standard (0.0 ppm). Insulin powder was dissolved in 600 mLc itrate phosphate buffer (pH 2.6) with D 2 Oc ontaining TSP. STD NMR spectroscopy was done for three samples:r eference, in the presence of insulin, and in the absence of insulin. [44] Atomiclevel dynamics were obtained from one-dimensional longitudinal (T 1 )a nd transverse (T 2 )r elaxation experiments. The T 1 experiments were performed by using previously reported protocols [54, 55] with different inversion recovery delays ranging from 0t o3s. The T 2 measurements were achieved from the CPMG sequence with delays ranging from 0t o0.7 s.
Antibodies and Reagents
The following antibodies and reagents were obtained commercially:a nti-phospho Akt (Ser473) antibody (4058, rabbit, Cell Signalling), anti-Akt (pan) antibody (4691, rabbit, Cell Signalling), and anti-a-actin antibody (mouse, Cell Signalling).
Western Blotting
For western blotting, cells were lysed in cell lysis buffer [50 mm Tris-HCl pH 7.2, 100 mm NaCl, 1mm EDTA( ethylenediaminetetraacetic acid) pH 8.0, 1mm EGTA( ethylene glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid), 1% Triton X100] and protease and phosphatase inhibitor tablets (Roche). 10 %R esolving gel (1.5 m Tris-HCl, pH 8.8) and 4% stacking gel (0.5 m Tris-HCl, pH 6.8) were cast in aG EH ealthcare MiniVes odium dodecyl sulfate (SDS) electrophoresis system. 10 %A PS (Himedia #MB003-25G), N,N,N',N'-tetramethylethylenediamine (TEMED) (Sigma #T9281-50ML), and 10 %S DS were added to cast the gel. Protein (30-50 mg) was prepared with 5 SDS sample loading dye (10 % b-mercaptoethanol) and boiled for 10 min at 95 8C. Then, the sample was kept on ice for 5min and centrifuged shortly and loaded. Run was performed at 90 Vf or 10 min and at 120 Vf or the rest of the duration. The transfer was done in MiniVet ransfer apparatus by using aM illipore polyvinylidene difluoride (PVDF) membrane (IPVH000-10). Transfer duration was either overnight at 25 Vor3ha t9 0Vat 4 8C, whereas 400 mA was preset. Membranes were kept in 1 PBST [1 phosphate-buffered saline (PBS), 1% Tween20 (Sigma #P1379IL)] for 5min then in 5% NFDM for 1h at room temperature. Then, the membranes were washed with 1 PBST (3 ), 5min each time, and incubated in desired primary antibody at 4 8Co vernight. After that, the membrane was washed with 1 PBST (3 )a nd incubated with appropriate secondary antibody for 1h at RT and then developed by using Millipore Luminata Classico (#WBLUC0500) or Luminata Forte (#WBLUF0100) HRP substrates and picture were captured in Gel Logic Carestream 400PRO.
Docking
Methylene blue was docked with insulin in Glide module by using the standard precision (SP) mode (Glide, version 5.5, Schrodinger, Inc.,N ew York, NY,2 009). The grid was prepared to cover the entire structure of insulin with dimensions of À29 7 40 .M B was docked with insulin to obtain a1:1 complex.
Molecular Dynamics Simulation
MD simulations were performed in Amber14 by using prmbsc0 modifications in conjunction with ff99SB force field for insulin. Parametrization of MB was performed in the simple harmonic function used by General Amber Force Field (GAFF) with AM1-BCC charge model. [56] The insulin-MB complex was already neutralized, so no extra ions were required to neutralize the system. TIP3P water model was used to solvate the system in an octahedral model with edge length extensions of 10 from solute atom. [57] The simulation was performed by using periodic boundary conditions with the particle-mesh Edward simulation method. [58] Lennard-Jones potentials and direct space interactions cut-off were 9 to correct for long-range van der Waals interactions. The SHAKE algorithm was used to restrain the hydrogen atoms with an integration time step of 2f s. [59] Energy minimization was performed under explicit solvent conditions. MD simulations were continued up to 100 ns, and the trajectory was collected at an interval of 2psf or all systems.
The trajectory of the MD simulation was analyzed by using the cpptraj module of Amber tools14. [51] 
